Aandelen in “Pools en andere hygiënische goede fabricage”

Aandeel Datum Koers Evolutie
vlag Kintara Therapeutics Inc 19:11 0,156 USD
-0,57% 		-0,57%

Nieuws over “Pools en andere hygiënische goede fabricage”

30/04 · Clorox Reports Q3 Fiscal Year 2024 Results, Updates Outlook · Persbericht

30/04 · Clorox Reports Q3 Fiscal Year 2024 Results, Updates Outlook · Persbericht

24/04 · Clorox to Present at Goldman Sachs Global Staples Forum · Persbericht

10/04 · Clorox Announces April 30 Webcast of Third-Quarter Fiscal Year 2024 Results · Persbericht

10/04 · STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRA · Persbericht

3/04 · Pine-Sol® Announces Reformulated Multi-Surface Cleaners, Delivering 2x the Cleaning Power · Persbericht

3/04 · Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement · Persbericht

27/03 · Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab · Persbericht

21/03 · Clorox Divests its Operations in Argentina, Uruguay and Paraguay · Persbericht

8/03 · Burt's Bees® Showcases Clinical Efficacy of Aloe and Prebiotic Containing Products in Addressing Common Skin Concerns · Persbericht

28/02 · Clorox Declares Regular Quarterly Dividend of $1.20 Per Share · Persbericht

22/02 · The Clorox Company Named Barron's Most Sustainable U.S. Company for Second Year in a Row · Persbericht

14/02 · Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update · Persbericht

13/02 · Mee m/d markt: 'Op naar Amerikaanse inflatiedata' · Bolero.be

Europese aandelen reflecteerden met zo’n 0,5% winst de stijging op Wall Street van vorige week vrijdag. Wie zei er ook alweer dat enkel de Chinezen kopiëren? Datzelfde Wall Street trappelde gisteren rond het nulpunt, maar...

12/02 · Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer · Persbericht

6/02 · Clorox to Present at 2024 CAGNY Conference · Persbericht

Mijn selecties